Jazz Pharmaceuticals (JAZZ) Short Interest Ratio & Short Volume

$108.32
-1.35 (-1.23%)
(As of 04/24/2024 ET)

Jazz Pharmaceuticals Short Interest Data

Current Short Volume
3,260,000 shares
Previous Short Volume
2,770,000 shares
Change Vs. Previous Month
+17.69%
Dollar Volume Sold Short
$392.57 million
Short Interest Ratio / Days to Cover
5.3
Last Record Date
March 31, 2024
Outstanding Shares
63,000,000 shares
Float Size
60,280,000 shares
Short Percent of Float
5.41%
Today's Trading Volume
401,278 shares
Average Trading Volume
608,323 shares
Today's Volume Vs. Average
66%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Jazz Pharmaceuticals ?

Sign up to receive the latest short interest report for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

JAZZ Short Interest Over Time

JAZZ Days to Cover Over Time

JAZZ Percentage of Float Shorted Over Time

Jazz Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20243,260,000 shares $392.57 million +17.7%5.4%5.3 $120.42
3/15/20242,770,000 shares $334.89 million +15.9%4.6%4.3 $120.90
2/29/20242,390,000 shares $284.17 million +3.0%4.0%4 $118.90
2/15/20242,320,000 shares $294.22 million +5.0%N/A4 $126.82
1/31/20242,210,000 shares $271.21 million +2.3%N/A3.4 $122.72
1/15/20242,160,000 shares $256.91 million -1.8%N/A3 $118.94
12/31/20232,200,000 shares $270.60 million -0.5%N/A3.1 $123.00
12/15/20232,210,000 shares $268.52 million -9.1%N/A3.1 $121.50
11/30/20232,430,000 shares $287.30 million -5.5%N/A3.6 $118.23
11/15/20232,570,000 shares $322.28 million -6.2%N/A4 $125.40
10/31/20232,740,000 shares $348.03 million +5.0%N/A4.5 $127.02
10/15/20232,610,000 shares $337.00 million -19.9%N/A4.7 $129.12
9/30/20233,260,000 shares $421.97 million -2.4%N/A6.9 $129.44
9/15/20233,340,000 shares $442.52 million +16.8%N/A6.8 $132.49
8/31/20232,860,000 shares $410.01 million +1.1%N/A5.4 $143.36
8/15/20232,830,000 shares $396.17 million -0.4%N/A5 $139.99
7/31/20232,840,000 shares $370.39 million -5.7%N/A5 $130.42
7/15/20233,010,000 shares $381.34 million +0.3%N/A5.3 $126.69
6/30/20233,000,000 shares $371.91 million +11.5%N/A5.4 $123.97
6/15/20232,690,000 shares $346.82 million -13.8%N/A5.1 $128.93
5/31/20233,120,000 shares $399.86 million +5.1%N/A6.3 $128.16
5/15/20232,970,000 shares $400.00 million +19.8%N/A6 $134.68
4/30/20232,480,000 shares $348.37 million +7.4%N/A5 $140.47
4/15/20232,310,000 shares $336.15 million -10.1%N/A4.8 $145.52
3/31/20232,570,000 shares $376.07 million +10.8%N/A5 $146.33
3/15/20232,320,000 shares $312.94 million -4.9%N/A4.4 $134.89
2/28/20232,440,000 shares $342.58 million -1.6%N/A4.2 $140.40
2/15/20232,480,000 shares $370.54 million -3.9%N/A4.6 $149.41
1/31/20232,580,000 shares $404.18 million -1.9%N/A4.6 $156.66
1/15/20232,630,000 shares $411.52 million -2.6%N/A4.8 $156.47
12/30/20222,700,000 shares $430.14 million +21.1%N/A5 $159.31
12/15/20222,230,000 shares $341.10 million +2.8%N/A4 $152.96
11/30/20222,170,000 shares $340.49 million -7.7%N/A4 $156.91
11/15/20222,350,000 shares $348.83 million -1.7%N/A4.5 $148.44
10/31/20222,390,000 shares $343.66 million +6.2%N/A4.7 $143.79
10/15/20222,250,000 shares $299.72 million -14.1%N/A4.3 $133.21
9/30/20222,620,000 shares $349.22 million -4.4%N/A5 $133.29
9/15/20222,740,000 shares $416.97 million -1.4%N/A5.3 $152.18
8/31/20222,780,000 shares $431.51 million No ChangeN/A5.7 $155.22
8/15/20222,780,000 shares $445.52 million +3.0%N/A5.4 $160.26
The system that called 2023’s top 7 stocks is at it again… (Ad)

Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.

Just follow this link here!

JAZZ Short Interest - Frequently Asked Questions

What is Jazz Pharmaceuticals' current short interest?

Short interest is the volume of Jazz Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 3,260,000 shares of JAZZ short. 5.41% of Jazz Pharmaceuticals' shares are currently sold short. Learn More on Jazz Pharmaceuticals' current short interest.

What is a good short interest ratio for Jazz Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JAZZ shares currently have a short interest ratio of 5.0. Learn More on Jazz Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Jazz Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Jazz Pharmaceuticals: Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Jazz Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.41% of Jazz Pharmaceuticals' floating shares are currently sold short.

Is Jazz Pharmaceuticals' short interest increasing or decreasing?

Jazz Pharmaceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 3,260,000 shares, an increase of 17.7% from the previous total of 2,770,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Jazz Pharmaceuticals' float size?

Jazz Pharmaceuticals currently has issued a total of 63,000,000 shares. Some of Jazz Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Jazz Pharmaceuticals currently has a public float of 60,280,000 shares.

How does Jazz Pharmaceuticals' short interest compare to its competitors?

5.41% of Jazz Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Jazz Pharmaceuticals: Perrigo Company plc (2.85%), Mirati Therapeutics, Inc. (6.26%), Corcept Therapeutics Incorporated (23.90%), Cytokinetics, Incorporated (13.33%), Viking Therapeutics, Inc. (8.64%), Intra-Cellular Therapies, Inc. (3.58%), Elanco Animal Health Incorporated (2.52%), Cerevel Therapeutics Holdings, Inc. (11.06%), Ionis Pharmaceuticals, Inc. (7.11%), Apellis Pharmaceuticals, Inc. (8.66%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Jazz Pharmaceuticals stock?

Short selling JAZZ is an investing strategy that aims to generate trading profit from Jazz Pharmaceuticals as its price is falling. JAZZ shares are trading down $1.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Jazz Pharmaceuticals?

A short squeeze for Jazz Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JAZZ, which in turn drives the price of the stock up even further.

How often is Jazz Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JAZZ, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:JAZZ) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners